USPTO serial 79273809
WMBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 8, 2020
- Examiner
- MACFARLANE, JAMES W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with WMBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard Y. Kim
Richard Y. Kim Snell & Wilmer L.L.P.400 East Van Buren Street, Suite 1900One Arizona CenterPhoenix, AZ 85004-2202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting sensory organs; vaccines; vitamin preparations; nervines in the nature of pharmaceutical preparations to calm the nerves; digestives for pharmaceutical purposes; alcohol for pharmaceutical purposes; pharmaceutical agents for epidermis; biological preparations for medical purposes, for treating cancer, diabetes and skin disorders; biological preparations for veterinary purposes, for treating cancer, diabetes, and skin disorders; drugs for medical purposes, for treating cancer, diabetes, and skin disorders; medicinal hair growth preparations; pharmaceuticals for humans, for treating cancer, diabetes, and skin disorders; pharmaceutical preparations for treating cancer, diabetes, and skin disorders; veterinary preparations for treating cancer, diabetes, and skin disorders; pharmaceutical preparations acting on the central nervous system, for treating cancer, diabetes, and skin disorders; therapeutic drugs and agents for treating cancer, diabetes, and skin disorders; antibiotic preparations; implants comprising living tissue; medical diagnostic test strips for biomarker analysis, blood analysis, urine analysis, and saliva analysis; bandages for dressings; adhesive bands for medical purposes; materials for dental fillings and for stopping teeth | ACTIVE | — |
| 042 | Research and development of vaccines and medicines; development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; research on the subject of pharmaceuticals; medical product testing; scientific research for medical products; scientific research in the fields of medicine, health and pharmacology; clinical trials, namely, product testing in the field of pharmaceuticals; medical research; medical research in the field of crude medicines; bacteriological research; drug discovery services; clinical testing of medicines in the nature of product testing; industrial research in the fields of medicine, health and pharmacology; scientific research in the field of pharmacy; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; medical and scientific research services in the field of cosmetics; research and development of new products; biotechnology research; genetic research; medical and scientific research involving DNA testing; medical and scientific research and product development in the field of DNA chips; medical and scientific research involving the structural and functional analysis of genomes; DNA screening for scientific research purposes; genetic testing for scientific research purposes; scientific research conducted using databases; medical and scientific research involving molecular analysis; product research and development of technology for biotechnology; consultancy in the field of biotechnology; advisory services relating to biotechnology; biotechnology services, namely, biotechnology research; genetic testing for scientific research purposes involving biological information checks; genetic testing for medical research purposes involving biological information checks; product research and development of medical apparatus and instruments for others; providing technical support services, namely, troubleshooting in the nature of diagnosing problems with medical diagnostic instruments; development of computer software for big data processing; development, updating and maintenance of software and database systems; computer programming in the medical field; providing computer software technical support services in the field of medical diagnostics; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Wellmarker Bio Co., LTD.
- Other trademarks owned by Wellmarker Bio Co., LTD.
- Other trademarks owned by Wellmarker Bio Co., LTD.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named WMBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 8, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 13, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 13, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 8, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 8, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 22, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 22, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 2, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 18, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 12, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 12, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 20, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 19, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 17, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 13, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |